Xiaoyan Kang
-
- Lung Cancer Research Studies 5
- Cancer Immunotherapy and Biomarkers 4
- Colorectal Cancer Treatments and Studies 3
-
- Cancer-related molecular mechanisms research 4
-
- Lung Cancer Treatments and Mutations 7
-
- Monoclonal and Polyclonal Antibodies Research 6
-
- Ovarian cancer diagnosis and treatment 4
-
- RNA modifications and cancer 4
- Co-authors
- Changyu WangHaifeng GuoXiaohong ChenQingmei YangXiaochun HuangYuhuan LiuYu FuXue Wu
- Partner nations
- ChinaUnited States
In The Last Decade
Xiaoyan Kang
26 papers receiving 130 citations
Peers
Comparison fields: 5 of 38
- Oncology 62
- Cancer Research 21
- Pulmonary and Respiratory Medicine 36
- Immunology 23
- Radiology, Nuclear Medicine and Imaging 23
Countries citing papers authored by Xiaoyan Kang
This map shows the geographic impact of Xiaoyan Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoyan Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoyan Kang more than expected).
Fields of papers citing papers by Xiaoyan Kang
This network shows the impact of papers produced by Xiaoyan Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoyan Kang. The network helps show where Xiaoyan Kang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiaoyan Kang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 8 | |
| 6 | 2024 | 10 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 3 | |
| 9 | 2024 | 1 | |
| 10 | 2024 | 1 | |
| 11 | 2024 | 3 | |
| 12 | 2024 | 3 | |
| 13 | 2023 | 3 | |
| 14 | 2023 | 1 | |
| 15 | 2022 | 6 | |
| 16 | 2021 | 2 | |
| 17 | 2020 | 6 | |
| 18 | 2020 | 16 | |
| 19 | 2017 | 0 | |
| 20 | Evaluation of carotid artery elasticity changes in patients with cerebral small vessel disease. | 2015 | 9 |
About Xiaoyan Kang
Xiaoyan Kang is a scholar working on Oncology, Reproductive Medicine and Cancer Research, having authored 31 papers that have together received 140 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (7 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), Lung Cancer Research Studies (5 papers), Ovarian cancer diagnosis and treatment (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), RNA modifications and cancer (4 papers), Cancer-related molecular mechanisms research (4 papers) and Colorectal Cancer Treatments and Studies (3 papers). The work is most often cited by research in Oncology (62 citations), Cancer Research (21 citations) and Pulmonary and Respiratory Medicine (36 citations). Xiaoyan Kang has collaborated with scholars based in China and United States. Frequent co-authors include Changyu Wang, Haifeng Guo, Xiaohong Chen, Qingmei Yang, Xiaochun Huang, Yuhuan Liu, Yu Fu, Xue Wu, Xiaoyu Liu and Dianxing Hu. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.